Literature DB >> 19104017

Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.

Edel O'Regan1, Teresa Quinn, Jean-Marie Pagès, Matthew McCusker, Laura Piddock, Séamus Fanning.   

Abstract

Mechanisms of antibiotic resistance were examined in nalidixic acid-resistant Salmonella enterica serovar Enteritidis field isolates displaying decreased susceptibility to ciprofloxacin and in in vitro-derived ciprofloxacin-resistant mutants (104-cip and 5408-cip). All field isolates harbored a single gyrA mutation (D87Y). Deletion of acrB and complementation with wild-type gyrA increased quinolone susceptibility. Selection for ciprofloxacin resistance was associated with the development of an additional gyrA (S83F) mutation in 104-cip, novel gyrB (E466D) and parE (V461G) mutations in 5408-cip, overexpression of acrB and decreased susceptibility to nonquinolone antibiotics in both mutants, and decreased OmpF production and altered lipopolysaccharide in 104-cip. Complementation of mutated gyrA and gyrB with wild-type alleles restored susceptibility to quinolones in 104-cip and significantly decreased the ciprofloxacin MIC in 5408-cip. Complementation of parE had no effect on quinolone MICs. Deletion of acrB restored susceptibility to ciprofloxacin and other antibiotics tested. Both soxS and marA were overexpressed in 104-cip, and ramA was overexpressed in 5408-cip. Inactivation of each of these global regulators lowered ciprofloxacin MICs, decreased expression of acrB, and restored susceptibility to other antibiotics. Mutations were found in soxR (R20H) and in soxS (E52K) in 104-cip and in ramR (G25A) in 5408-cip. In conclusion, both efflux activity and a single gyrA mutation contribute to nalidixic acid resistance and reduced ciprofloxacin sensitivity. Ciprofloxacin resistance and decreased susceptibility to multiple antibiotics can result from different genetic events leading to development of target gene mutations, increased efflux activity resulting from differential expression of global regulators associated with mutations in their regulatory genes, and possible altered membrane permeability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104017      PMCID: PMC2650546          DOI: 10.1128/AAC.01005-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  49 in total

1.  Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis.

Authors:  F J Vasallo; P Martín-Rabadán; L Alcalá; J M García-Lechuz; M Rodríguez-Créixems; E Bouza
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

2.  RobA-induced multiple antibiotic resistance largely depends on the activation of the AcrAB efflux.

Authors:  T Tanaka; T Horii; K Shibayama; K Sato; S Ohsuka; Y Arakawa; K Yamaki; K Takagi; M Ohta
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

Review 3.  Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon.

Authors:  M N Alekshun; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

4.  Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae.

Authors:  Alexey Ruzin; Melissa A Visalli; David Keeney; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 5.  Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments.

Authors:  Katie L Hopkins; Robert H Davies; E John Threlfall
Journal:  Int J Antimicrob Agents       Date:  2005-05       Impact factor: 5.283

6.  The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence.

Authors:  M C Sulavik; M Dazer; P F Miller
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

7.  Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.

Authors:  Monique Mallea; Jacqueline Chevalier; Charleric Bornet; Annie Eyraud; Anne Davin-Regli; Claude Bollet; Jean-Marie Pages
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

8.  Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.

Authors:  L J Piddock; V Ricci; I McLaren; D J Griggs
Journal:  J Antimicrob Chemother       Date:  1998-06       Impact factor: 5.790

9.  Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.

Authors:  M Oethinger; I Podglajen; W V Kern; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.

Authors:  Yousef M Abouzeed; Sylvie Baucheron; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

View more
  38 in total

1.  Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.

Authors:  Elizabeth M Grimsey; Natasha Weston; Vito Ricci; Jack W Stone; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

2.  ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline.

Authors:  M Hentschke; M Wolters; I Sobottka; H Rohde; M Aepfelbacher
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

Review 3.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 4.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

5.  Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates.

Authors:  Michael Feldgarden; Vyacheslav Brover; Daniel H Haft; Arjun B Prasad; Douglas J Slotta; Igor Tolstoy; Gregory H Tyson; Shaohua Zhao; Chih-Hao Hsu; Patrick F McDermott; Daniel A Tadesse; Cesar Morales; Mustafa Simmons; Glenn Tillman; Jamie Wasilenko; Jason P Folster; William Klimke
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

6.  Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics.

Authors:  Tânia Curiao; Emmanuela Marchi; Carlo Viti; Marco R Oggioni; Fernando Baquero; José Luis Martinez; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

7.  OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland.

Authors:  Salome N Seiffert; Vincent Perreten; Sönke Johannes; Sara Droz; Thomas Bodmer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

8.  Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae.

Authors:  Shyamasree De Majumdar; Mark Veleba; Sarah Finn; Séamus Fanning; Thamarai Schneiders
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

9.  Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.

Authors:  Lucas R Hoffman; Anthony R Richardson; Laura S Houston; Hemantha D Kulasekara; Willm Martens-Habbena; Mikkel Klausen; Jane L Burns; David A Stahl; Daniel J Hassett; Ferric C Fang; Samuel I Miller
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

10.  Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant.

Authors:  Anna Fàbrega; Laurence du Merle; Chantal Le Bouguénec; M Teresa Jiménez de Anta; Jordi Vila
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.